moxifloxacin has been researched along with Apoplexy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, J; Dirnagl, U; Halle, E; Megow, D; Meisel, A; Meisel, C; Prass, K; Victorov, I; Volk, HD; Wolf, T | 1 |
| Arnold, G; Bereswill, S; Dirnagl, U; Drenckhahn, C; Göbel, U; Göhler, J; Halle, E; Harms, H; Klehmet, J; Meisel, A; Meisel, C; Prass, K; Rogge, W; Volk, HD; Wernecke, KD; Wolf, T | 1 |
1 trial(s) available for moxifloxacin and Apoplexy
| Article | Year |
|---|---|
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Body Temperature; Brain Ischemia; C-Reactive Protein; Double-Blind Method; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Placebos; Quinolines; Respiration, Artificial; Risk Factors; Stroke; Survival Analysis | 2008 |
2 other study(ies) available for moxifloxacin and Apoplexy
| Article | Year |
|---|---|
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.
Topics: Animals; Antibiotic Prophylaxis; Aza Compounds; Bacterial Infections; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Fever; Fluoroquinolones; Gram-Positive Bacterial Infections; Hypothermia; Immune Tolerance; Male; Mice; Mice, Inbred Strains; Moxifloxacin; Opportunistic Infections; Pneumonia, Bacterial; Quinolines; Sepsis; Stroke; Survival Rate; Treatment Outcome | 2004 |
[After stroke threatens pneumonia. Antibiotics to be given prophylactically?].
Topics: Animals; Antibiotic Prophylaxis; Aza Compounds; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Placebos; Pneumonia; Quinolines; Stroke; Time Factors | 2004 |